Ensuring Early Diagnosis and Targeting Treatment to Remission in Patients with Rheumatoid Arthritis: Recommendations for Primary Care Clinicians (ID: i727a) Survey

Question Title

* 1. Following your participation in this activity, how confident are you in the management of patients with RA in your practice?

Very confident

Confident

Neutral

Little confidence

No confidence

Question Title

* 2. How many patients with RA do you currently manage in your practice? Please respond with your best appropriate number.

Question Title

* 3. How many years have you been in practice?

1-10

11-20

≥21

Question Title

* 4. Which of the following best describes the impact of this activity on your performance?

I gained new strategies/skills/information that I can apply to my area of practice.

I need more information before I change my practice behavior.

This activity will not change my practice, as my current practice is consistent with the information presented.

This activity will not change my practice, as I do not agree with the information presented.

Question Title

* 5. How committed are you to making changes in your practice based on your participation in this activity?

Very committed

Committed

Neutral

Not committed

I do not plan to make changes.

Question Title

* 6. After participating in today’s activity, I am now able to:

	Strongly agree	Agree	Neutral	Disagree	Strongly disagree
Implement routine screening to improve early diagnosis of RA	Implement routine screening to improve early diagnosis of RA Strongly agree	Implement routine screening to improve early diagnosis of RA Agree	Implement routine screening to improve early diagnosis of RA Neutral	Implement routine screening to improve early diagnosis of RA Disagree	Implement routine screening to improve early diagnosis of RA Strongly disagree
Apply a treat-to-target approach that is consistent with current guideline recommendations for RA management	Apply a treat-to-target approach that is consistent with current guideline recommendations for RA management Strongly agree	Apply a treat-to-target approach that is consistent with current guideline recommendations for RA management Agree	Apply a treat-to-target approach that is consistent with current guideline recommendations for RA management Neutral	Apply a treat-to-target approach that is consistent with current guideline recommendations for RA management Disagree	Apply a treat-to-target approach that is consistent with current guideline recommendations for RA management Strongly disagree
Describe the mechanisms of action of approved targeted therapies for the treatment of RA	Describe the mechanisms of action of approved targeted therapies for the treatment of RA Strongly agree	Describe the mechanisms of action of approved targeted therapies for the treatment of RA Agree	Describe the mechanisms of action of approved targeted therapies for the treatment of RA Neutral	Describe the mechanisms of action of approved targeted therapies for the treatment of RA Disagree	Describe the mechanisms of action of approved targeted therapies for the treatment of RA Strongly disagree
Utilize strategies for early identification of important comorbidities and their management in patients with RA	Utilize strategies for early identification of important comorbidities and their management in patients with RA Strongly agree	Utilize strategies for early identification of important comorbidities and their management in patients with RA Agree	Utilize strategies for early identification of important comorbidities and their management in patients with RA Neutral	Utilize strategies for early identification of important comorbidities and their management in patients with RA Disagree	Utilize strategies for early identification of important comorbidities and their management in patients with RA Strongly disagree

Question Title

* 7. Roy Fleischmann, MD, effectively:

	Strongly agree	Agree	Neutral	Disagree	Strongly disagree
Presented the material	Presented the material Strongly agree	Presented the material Agree	Presented the material Neutral	Presented the material Disagree	Presented the material Strongly disagree
Avoided commercial bias	Avoided commercial bias Strongly agree	Avoided commercial bias Agree	Avoided commercial bias Neutral	Avoided commercial bias Disagree	Avoided commercial bias Strongly disagree

Question Title

* 8. The content presented:

	Strongly agree	Agree	Neutral	Disagree	Strongly disagree
Enhanced my current knowledge base	Enhanced my current knowledge base Strongly agree	Enhanced my current knowledge base Agree	Enhanced my current knowledge base Neutral	Enhanced my current knowledge base Disagree	Enhanced my current knowledge base Strongly disagree
Addressed my most pressing questions	Addressed my most pressing questions Strongly agree	Addressed my most pressing questions Agree	Addressed my most pressing questions Neutral	Addressed my most pressing questions Disagree	Addressed my most pressing questions Strongly disagree
Promoted improvements or quality in health care	Promoted improvements or quality in health care Strongly agree	Promoted improvements or quality in health care Agree	Promoted improvements or quality in health care Neutral	Promoted improvements or quality in health care Disagree	Promoted improvements or quality in health care Strongly disagree
Was scientifically rigorous and evidence based	Was scientifically rigorous and evidence based Strongly agree	Was scientifically rigorous and evidence based Agree	Was scientifically rigorous and evidence based Neutral	Was scientifically rigorous and evidence based Disagree	Was scientifically rigorous and evidence based Strongly disagree
Avoided commercial bias or influence	Avoided commercial bias or influence Strongly agree	Avoided commercial bias or influence Agree	Avoided commercial bias or influence Neutral	Avoided commercial bias or influence Disagree	Avoided commercial bias or influence Strongly disagree

Question Title

* 9. As a result of your participation in this activity, what strategies/changes do you plan to implement in your practice?

Question Title

* 10. What barriers do you see to making changes in your practice?

Question Title

* 11. Please list any clinical issues/problems within your scope of practice you would like to see addressed in future educational activities:

Question Title

* 12. If you indicated that you perceived commercial bias or influence, please describe:

Question Title

* 13. How would you rate the format of this activity?

Excellent

Average

Below average

Poor